Putting you at the centre of all decisions affecting your health
30% of the European population lives with allergies, asthma and COPD
Because breathing is taken for granted, we work for better recognition of chronic respiratory diseases

Our funding partners

EFA operates with funding from membership fees, public EU funding, private unrestricted core-funding and project funding from corporate sources and donations that are disclosed every year. EFA ensures that all forms of funding are open and transparent, ensuring accountability to its sponsors and partners. EFA has a Code of Ethics and Conduct and retains a sustainable partnership with industry to ensure its integrity when receiving funding from corporate sources.

 

Our Annual Report

The Annual Report, including audited financial accounts and overall budget for the next year is approved by the Annual General Meeting of Members.

Here are the reports from 201420132012201120102009200820072006 and 2005.

Our budget is also disclosed by percentage per sponsor and funding source for 2014, following the the Funding Table for the European Medicines Agency (EMA).

 

2014 Annual Accounts

EFA thanks sincerily our funding partners who have made our work in 2014 possible:

European Commission

 

Operating grant European Agency for Health and Consumers

221.524,27

DG Research FP7 project: MEDALL 

3.247,72
   

Sustainable partnership with industry

 

- Operating programme sustainability

 

Air Liquide Sante International 

8.000,00

ALK Abello 

8.000,00

Almirall 

8.000,00

Boehringer Ingelheim International 

8.000,00

GSK 

8.000,00

Novartis 

8.000,00

Sanofi Pasteur MSD 

8.000,00

Stallergenes 

8.000,00

- Project programme sustainability

 

Air Liquide Sante International 

20.000,00

ALK Abello 

20.000,00

Almirall 

20.000,00

Boehringer Ingelheim International

20.000,00

GSK 

20.000,00

Novartis

20.000,00

Sanofi Pasteur MSD 

20.000,00

Stallergenes France

20.000,00

Donation: Chiesi Farmeceutici

15.000,00

Donation: Mundipharma International

4.407,48
EFA Allergy Project
 

ALK Abello 

25.000,00

Stallergenes France 

25.000,00
EFA Asthma Project
 
Novartis  30.000,00
EFA Capacity Building Project
 

Boehringer Ingelheim International 

32.000,00

Novartis 

30.000,00
EFA COPD Project
 
Novartis  40.000,00